[Federal Register Volume 80, Number 203 (Wednesday, October 21, 2015)]
[Notices]
[Pages 63790-63791]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-26759]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Docket Number CDC-2015-0090; NIOSH 248-C]


Meeting: World Trade Center Health Program Scientific/Technical 
Advisory Committee (WTCHP STAC or Advisory Committee), National 
Institute for Occupational Safety and Health (NIOSH)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC), announces the following meeting of the aforementioned 
committee:
    Time and Date: 9 a.m.-5 p.m., Eastern Standard Time, December 1, 
2015
    Place: Jacob J. Javits Federal Building, 26 Federal Plaza, New 
York, New York 10278. This meeting is also available by teleconference. 
The USA toll-free, dial-in number is 1-888-455-9749, and when prompted 
enter passcode--6542002. To view the web conference, enter the 
following web address in your web browser: https://odniosh.adobeconnect.com/wtchpstac/.
    Public Comment Time and Date: 11:20 a.m.-12 p.m., Eastern Standard 
Time, December 1, 2015
    Please note that the public comment period ends at the time 
indicated above or following the last call for comments, whichever is 
earlier. Members of the public who want to comment must sign up by 
providing their name by mail, email, or telephone, at the addresses 
provided below by November 27, 2015. Each commenter will be provided up 
to five minutes for comment. A limited number of time slots are 
available and will be assigned on a first come-first served basis. 
Written comments will also be accepted from those unable to attend the 
public session.
    Status: Open to the public, limited only by the number of telephone 
lines. The conference line will accommodate up to 50 callers; therefore 
it is suggested that those interested in calling in to listen to the 
committee meeting share a line when possible.
    Background: The Advisory Committee was established by Public Law 
111-347 (The James Zadroga 9/11 Health and Compensation Act of 2010, 
Title XXXIII of the Public Health Service Act), enacted on January 2, 
2011 and codified at 42 U.S.C. 300mm-300mm-61.
    Purpose: The purpose of the Advisory Committee is to review 
scientific and medical evidence and to make recommendations to the 
Administrator of the World Trade Center (WTC) Health Program regarding 
additional WTC Health Program eligibility criteria and potential 
additions to the list of covered WTC-related health conditions, as well 
as providing consultation on research to the Administrator of the World 
Trade Center Health Program. Title XXXIII of the Public Health Service 
Act established within the Department of Health and Human Services 
(HHS), the World Trade Center (WTC) Health Program, to be administered 
by the Administrator of the World Trade Center Health Program. The WTC 
Health Program provides: (1) Medical monitoring and treatment benefits 
to eligible emergency responders and recovery and cleanup workers 
(including those who are Federal employees) who responded to the 
September 11, 2001, terrorist attacks, and (2) initial health 
evaluation, monitoring, and treatment benefits to residents and other 
building occupants and area workers in New York City, who were directly 
impacted and adversely affected by such attacks (``survivors''). 
Certain specific activities of the Administrator of the World Trade 
Center Health Program are reserved to the Secretary, HHS, to delegate 
at her discretion; other duties of the Administrator of the World Trade 
Center Health Program not explicitly reserved to the Secretary, HHS, 
are assigned to the Director, NIOSH. The administration of the Advisory 
Committee established under Section 300mm-1(a) is left to the Director 
of NIOSH in his role as Administrator of the World Trade Center Health 
Program. CDC and NIOSH provide funding,

[[Page 63791]]

staffing, and administrative support services for the Advisory 
Committee. The charter was reissued on May 12, 2015, and will expire on 
May 12, 2017.
    Matters for Discussion: The Advisory Committee will continue its 
deliberations from the meeting on June 4, 2015, addressing the need for 
research on developmental or health effects in children. The agenda 
will include presentations on children's health research that has been 
conducted related to exposures from the 9/11 terrorist attacks. Also, a 
panel of children's researchers will discuss children's research issues 
with the Advisory Committee.
    The agenda is subject to change as priorities dictate.
    Public Comment Sign-up and Submissions to the Docket: To sign up to 
provide public comments or to submit comments to the docket, send 
information to the NIOSH Docket Office by one of the following means:
    Mail: NIOSH Docket Office, Robert A. Taft Laboratories, C-34, 1090 
Tusculum Avenue, Cincinnati, Ohio 45226.
    Email: [email protected].
    Telephone: (513) 533-8611.
    In the event an individual cannot attend, written comments may be 
submitted. The comments should be limited to two pages and submitted 
through http://www.regulations.gov by November 27, 2015. Efforts will 
be made to provide the two-page written comments received by the 
deadline below to the committee members before the meeting. Comments in 
excess of two pages will be made publicly available at http://www.regulations.gov. To view background information and previous 
submissions go to NIOSH docket http://www.cdc.gov/niosh/docket/archive/docket248.html , http://www.cdc.gov/niosh/docket/archive/docket248-A.html, and http://www.cdc.gov/niosh/docket/archive/docket248-B.html.
    Policy on Redaction of Committee Meeting Transcripts (Public 
Comment): Transcripts will be prepared and posted to http://www.regulations.gov within 60 days after the meeting. If a person 
making a comment gives his or her name, no attempt will be made to 
redact that name. NIOSH will take reasonable steps to ensure that 
individuals making public comments are aware of the fact that their 
comments (including their name, if provided) will appear in a 
transcript of the meeting posted on a public Web site. Such reasonable 
steps include a statement read at the start of the meeting stating that 
transcripts will be posted and names of speakers will not be redacted. 
If individuals in making a statement reveal personal information (e.g., 
medical information) about themselves, that information will not 
usually be redacted. The CDC Freedom of Information Act coordinator 
will, however, review such revelations in accordance with the Freedom 
of Information Act and, if deemed appropriate, will redact such 
information. Disclosures of information concerning third party medical 
information will be redacted.
    Contact Person for More Information: Paul J. Middendorf, Ph.D., 
Designated Federal Officer, NIOSH, CDC, 2400 Century Parkway NE., Mail 
Stop E-20, Atlanta, GA 30345, telephone 1 (888) 982-4748; email: [email protected].
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register Notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention, and the Agency 
for Toxic Substances and Disease Registry.

Catherine Ramadei,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2015-26759 Filed 10-20-15; 8:45 am]
BILLING CODE 4163-18-P